Steroid/Antibiotic (Maxitrol)

Phase 1Small molecule

VVirginia Commonwealth University

Steroid/Antibiotic (Maxitrol) is one of 14 small molecule programs targeting Outcome. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

OutcomeNot yet recruiting

OutcomePhase 1

Not yet recruiting

Competition

Competitive Landscape

20 competitors in Outcome

#DrugCompanyPhaseTrials

Victoza

Novo Nordisk

Approved

1 2

Promacta

GSK

Phase 3

1 3

Vafseo

AAkebia Therapeutics

Phase 3

1 4

Keytruda

Merck & Co.

Phase 2

1 5

Ozempic

Novo Nordisk

Phase 1

1 6

T89

TTasly Pharmaceuticals, Inc.

Phase 3

1 7

Amidate

Pfizer

Preclinical

2 8

Estrasorb

Novo Nordisk

Preclinical

2 9

Savaysa

Daiichi Sankyo

Preclinical

1 10

Coenzyme Q10 Forte

AAin Shams University

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

Phase 1Not yet recruiting

Outcome

NCT06362226

Clinical

Trials by Indication[1]

Outcome1 trial

Optimizing Ocular Outcomes: A Dual-armed Study for Periorbital Burn Management

Not yet recruiting·VVirginia Commonwealth University·Phase 1·NCT06362226·10 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Steroid/Antibiotic (Maxitrol). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Steroid/Antibiotic (Maxitrol) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Steroid/Antibiotic (Maxitrol). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Virginia Commonwealth University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: VVirginia Commonwealth University

Steroid/Antibiotic (Maxitrol)

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2027

Trials by Indication[1]

Outcome1 trial

References

Drug Info

Quick Facts

Related News